logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11780912 B1

PDFFull Text
Date of Patent:
Oct. 10, 2023

Filed:

May. 28, 2021

Composition for prophylaxis or treatment of il-8 related diseases

Applicants:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Jichi Medical University, Tokyo, JP;

National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, JP;

Inventors:

Ayako Kakiuchi, Kanagawa, JP;

Atsuhiko Kato, Shizuoka, JP;

Shuji Hayashi, Shizuoka, JP;

Izumi Yanagisawa, Kanagawa, JP;

Ryo Konno, Saitama, JP;

Sachiho Netsu, Saitama, JP;

Tadashi Sankai, Ibaraki, JP;

Assignees:

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Jichi Medical University, Tokyo, JP;

National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, JP;

Attorney:

Nixon & Vanderhye P.C.

Primary Examiner:

Prema M Mertz

Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/24 (2006.01); A61P 15/00 (2006.01); A61P 29/00 (2006.01); A61P 11/00 (2006.01); A61K 45/00 (2006.01); A61P 1/16 (2006.01); A61K 39/395 (2006.01); A61P 13/12 (2006.01); A61P 43/00 (2006.01); A61P 17/06 (2006.01); A61P 15/08 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); A61K 45/00 (2013.01); A61P 1/16 (2018.01); A61P 11/00 (2018.01); A61P 13/12 (2018.01); A61P 15/00 (2018.01); A61P 15/08 (2018.01); A61P 17/06 (2018.01); A61P 29/00 (2018.01); A61P 43/00 (2018.01); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 16/24 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

For example, therapeutic methods and the like for novel IL-8-related diseases using an IL-8 signal inhibitor are provided. Alternatively, for example, therapeutic methods and the like for known or novel IL-8-related diseases using a novel anti-IL-8 antibody are provided.

Find Patent Forward Citations

Loading…